In a report published Wednesday in Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine) investigators from the University of Tübingen reported all nine subjects (100%)...

The end of a year gives us an opportunity to reflect on the year that was and make lists of things that made an impact in our lives. The positive impact of vaccines on the lives of individuals and families...

Results from a first-in-human phase 1 study reveal a weakened form of the malaria parasite safely activated strong immune responses in 10 healthy volunteers, whose antibodies completely protected mice...

The world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, WHO confirmed today. Funding is now secured for the initial phase of the programme and vaccinations are due...

Rockville, MD biotech company, Sanaria, announced Thursday that it has received U.S. Food and Drug Administration (FDA) Fast Track designation for its preventative vaccine for malaria, Sanaria® PfSPZ...

An experimental malaria vaccine protected a small number of healthy, malaria-naïve adults in the United States from infection for more than one year after immunization, according to results from a Phase...

By

In a follow-up to a report from 2012, the European Medicines Agency’s Committee for Medicinal Products for Human Use(CHMP) has adopted a positive scientific opinion for Mosquirix (Plasmodium falciparum and...

A recent crowdfunding campaign, launched on May 06, 2014, has already received national attention for it’s lofty but entirely feasible goal: eliminate the scourge of malaria by raising $250,000 to develop...